Opinion

Video

Discussing Seladelpar as a Potential Therapeutic for PBC

Panelists discuss how seladelpar showed remarkable efficacy in the RESPONSE trial, demonstrating significant improvements in alkaline phosphatase levels and other biochemical markers compared with placebo.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.